| 摘要 |
Dental therapeutics containing (1) parathyroid hormone (PTH) or one or more PTH derivatives or (2) parathyroid hormone (PTH) or one or more PTH derivatives and estrogen as an active ingredient or active ingredients have various actions such as increasing the bone density of the jaw alveolar bone portion, particularly the one in the upper jaw or the lower jaw, preventing or treating the weakening of the jaw alveolar bone portion, particularly the one in the upper jaw or the lower jaw, promoting the regeneration of the jaw alveolar bone portion, particularly the one in the upper jaw or the lower jaw, and increasing the bone densities of the whole mandibular bone and the mandibular molar portion after tooth removal; hence, they are clinically effective.
|
